New Delhi raised concerns about the hurdles
faced by its pharma exports to Australia, but welcomed Australia's decision to
reverse the ban on selling uranium to India.
India, which is engaged with Australia in negotiations for a Comprehensive Economic Cooperation Agreement, also hoped to conclude the agreement by mid-2012.
In a meeting, a senior official said Australia's decision on uranium was in line with the strategic nature of the relationship between the two countries. However, an Indian official pointed out that India's pharmaceutical exports to Australia require approvals from the Therapeutic Goods Administration, whose approval process is a long and expensive one. There is no recognition or concession to Indian companies with FDA approval or GMP certificate, he said.
Officials suggested using the services of Australian professionals for drawing out a standard to be followed by the Indian companies, to in turn help them get permission to export their medicines to Australia.
India, which is engaged with Australia in negotiations for a Comprehensive Economic Cooperation Agreement, also hoped to conclude the agreement by mid-2012.
In a meeting, a senior official said Australia's decision on uranium was in line with the strategic nature of the relationship between the two countries. However, an Indian official pointed out that India's pharmaceutical exports to Australia require approvals from the Therapeutic Goods Administration, whose approval process is a long and expensive one. There is no recognition or concession to Indian companies with FDA approval or GMP certificate, he said.
Officials suggested using the services of Australian professionals for drawing out a standard to be followed by the Indian companies, to in turn help them get permission to export their medicines to Australia.
No comments:
Post a Comment